MedCity News July 17, 2024
Thyme Care’s Series C funding round includes investments from Concord Health Partners, CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures and Foresite Capital.
Thyme Care, a value-based cancer care company, has secured $95 million in Series C funding, which it will use to grow its business, the company announced Tuesday.
Nashville, Tennessee-based Thyme Care, founded in 2020, partners with health plans, employers and risk-bearing providers in 31 states to support patients battling cancer. It offers care navigation services, technology and data insights and therapeutic interventions. The company helps patients understand their diagnosis, find a cancer doctor and receive clinical care between appointments. Patients also gain access to a team of providers,...
Today's Sponsors
Today's Sponsor